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ABSTRACT 
Type 1 Diabetes Mellitus is an autoimmune disease where pancreatic b-cells within the 
Islets of Langerhans are destroyed. A complication associated with type 1 diabetes mellitus is 
diabetic ketoacidosis, and if left untreated can result in coma or death. There are commercial 
methods for individuals to analyze ketone body concentrations within urine and blood, but these 
are invasive, expensive, and aren’t always accurate. Therefore, saliva should be examined as a 
potential alternative to the current commercial methods on the market. This experiment aimed to 
quantify the amount of beta-hydroxybutyrate and acetoacetate, in the saliva, blood, and urine 
samples using GC-MS by inducing ketosis in consenting participants. The participants followed a 
ketogenic diet for four days, and their biological samples were obtained before and after. The blood 
samples were centrifuged to isolate the plasma and deproteinated. All sample matrices were 
evaporated, the ketone bodies were derivatized using BSTFA + 1% TMCS at 80°C for 1.5 h, and 
the headspace was analyzed. The participants followed an Atkins diet to induce ketosis and the 
amount of beta-hydroxybutyrate was able to be quantified for each participant. The urine samples 
had high concentrations of beta-hydroxybutyrate, which could be a result of the acidic urine 
increasing the derivatization efficiency. There was very little beta-hydroxybutyrate detected within 
saliva. Since there was detection, this could potentially be used as a method to quantify ketone 
bodies upon further method development. No acetoacetate was detected in any of the samples. 
Future work should further optimize the methodology to detect acetoacetate, and the addition of 
recovery and internal standards to the samples to ensure all the analyte is derivatized and to 
determine if there is any variation between runs.  
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1.0 INTRODUCTION 
1.1 Type 1 Diabetes Mellitus 
Diabetes mellitus is an epidemic in today’s world with 600 million people worldwide being 
diagnosed as diabetic with 10% of those patients being diagnosed with type 1 diabetes mellitus 
(T1D) (Dholakia et al. 2016). T1D is an autoimmune disease where pancreatic b-cells within the 
Islets of Langerhans are destroyed, and the individual can no longer produce insulin. 
Unfortunately, the mechanism that triggers the autoimmune destruction of b-cells is unknown,  but 
T1D pathogenesis is being hypothesized to be in three stages (Butalia et al. 2016; Pociot and 
Lernmark 2016). In the first stage, b-cell autoantibodies are present, but inactive (Pociot and 
Lernmark 2016). The second stage involves the autoantibodies attacking the b-cells once some 
sort of environmental trigger occurs, and the third stage involves the symptoms of T1D to be 
present (Pociot and Lernmark 2016). The pathogenesis of T1D seems to be a combination of many 
factors. For instance, there are many genetic loci that are attributed to increasing the chances of 
being diagnosed with T1D like the human leukocyte antigen class II molecules, DQ and DR, within 
the major histocompatibility complex locus, and more are being discovered still (Butalia et al. 
2016; Pociot and Lernmark 2016). As well, certain environmental factors contribute to the 
increased risk of T1D like the mumps, rubella, microorganisms, and other factors which are still 
being studied (Butalia et al. 2016). Individuals with T1D have to monitor their blood glucose level 
every 4-8 h with the goal of being in a range of 4.0 to 7.0 mmol/L (Giugliano et al. 2008; Morales 
and Schneider 2014). If they are less than 3.9 mmol/L, they would have hypoglycemia and 
typically are treated with juice (Morales and Schneider 2014). Blood sugar levels consistently 
greater than 7.0 mmol/L while fasting refers to hyperglycemia and is treated with exogenously 
administered insulin (Giugliano et al. 2008).  
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There are many complications associated with T1D. For instance, those with T1D are prone 
to end-stage renal disease, blindness, foot and leg amputations, and cardiovascular diseases (Pociot 
and Lernmark 2016). Another complication of T1D is diabetic ketoacidosis. Essentially, it is a 
metabolic state in which the diabetic individual does not have enough insulin to stimulate glucose 
uptake by target cells, thus excreting glucose via urine, and increasing concomitantly the blood 
glucagon concentration which stimulates ketogenesis within the liver, and the excess of ketone 
bodies ends up acidifying the individuals blood (Laffel 1999; Mullins et al. 2011). By clinical 
definition, one is diagnosed with diabetic ketoacidosis when they have a blood glucose level 
greater than 11 mmol/L, a pH less than 7.3, ketonaemia, and ketonuria (Usher-Smith et al. 2011). 
One is considered in ketonaemia when blood ketone concentration is greater than 3 mM (Laffel 
1999). The amount of ketone bodies can be as high as 25 mM in those suffering from T1D (Laffel 
1999; Kanikarla-Marie and Jain 2016). In non-diabetic populations, ketoacidosis generally not a 
concern since these individuals have two feedback loops to maintain plasma ketone levels below 
3 mM (Mullins et al. 2011). 
Ketone bodies are ionized at physiological pH, so the hydrogen ions bind to the bicarbonate 
molecules, which tends to overwhelm the blood-buffering capacity and subsequently acidifies the 
blood (Laffel 1999; Mullins et al. 2011; Kanikarla-Marie and Jain 2016). This also leads to the 
loss of sodium ions, loss of ammonium, severe dehydration, and the loss of blood volume (Mullins 
et al. 2011). Those with T1D also struggle to clear ketone bodies through urine, whether or not 
they are suffering from ketoacidosis, and have decreased succinyl CoA-oxoacid transferase 
(SCOT) and 3-hydroxybutyrate dehydrogenase activities thus increasing ketone concentration 
within the blood (Kanikarla-Marie and Jain 2016; Sherwin et al.). If left untreated, this can result 
in coma or death and is the leading cause of death among children with T1D (Mullins et al. 2011; 
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Usher-Smith et al. 2011). This is concerning because between 10% and 70% of children recently 
diagnosed with T1D are in diabetic ketoacidosis, so it is crucial that the symptoms of diabetic 
ketoacidosis is acted upon and subsequently treated (Usher-Smith et al. 2011). Ketoacidosis is 
treated using insulin, potassium bicarbonate, and saline, which treat hyperglycemia, the lack of 
electrolytes within the individual and balance pH, and treat dehydration, respectively (Laffel 1999; 
Kanikarla-Marie and Jain 2016).  
 
1.2 Ketogenic Diets and Ketone Bodies  
Ketogenic diets (KD) have become very popular for those wishing to lose weight. KDs are 
a high-fat, moderate protein, and low carbohydrate intake diet that reduces glucose supply to 
decrease glycolysis and increase fatty acid breakdown through beta-oxidation (Branco et al. 2016; 
Roehl and Sewak 2017). Initially, acetyl-CoA is generated from fatty acid oxidation and can be 
used by the citric acid cycle to produce ATP. Using acetyl-CoA, the ketone bodies acetoacetate 
(AcAc), acetone, and beta-hydroxybutyrate (BHB) can be produced which serves as an energy 
source for the brain, the heart, the kidney cortex, and skeletal muscle (Laffel 1999; Roehl and 
Sewak 2017). The production of ketone bodies are necessary since they are water soluble, allowing 
energy sources to travel systemically, and can subsequently travel through the brain-blood barrier 
to enter neurons and generate ATP through their mitochondria (Mullins et al. 2011; Wibisono et 
al. 2015). There are four different types of KD which are the long-chain triglyceride KD (classic 
KD), modified Atkins diet, medium-chain triglyceride KD, and low glycemic index treatment 
(Branco et al. 2016; Roehl and Sewak 2017). The diets differ in the ratio of grams of fat consumed 
to grams of protein and carbohydrates consumed, percentage of calories consumed, and in the 
foods that are allowed to be consumed (Branco et al. 2016; Roehl and Sewak 2017). Originally, 
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KD was created in 1921 as a way to treat epilepsy, as it is believed to induce anticonvulsant effects 
in humans which affects neuronal firing and the spread of seizures (Branco et al. 2016). It has also 
been used as a therapeutic diet for those suffering from type II diabetes mellitus, obesity, and 
cancer (Wibisono et al. 2015; Branco et al. 2016; Roehl and Sewak 2017). The diet affects 
cancerous cells by reversing redox signaling pathways within tumors (Branco et al. 2016). Though 
it has been used therapeutically, there are potential short-term and long-term harms of the diet. In 
the short-term, participants may experience constipation, hypoglycemia, dehydration, lethargy, 
and acidosis (Branco et al. 2016). Long-term effects include hypercholesterolaemia, 
nephrolithiasis, and cardiomyopathy (Branco et al. 2016).  
 
Figure 1. The ketone bodies that is produced within the human body. 
 
Individuals on KDs usually go into ketosis, which refers to a metabolic state where ketone 
bodies are metabolized to produce ATP (Branco et al. 2016). Under normal physiological 
conditions, the ketone concentration within plasma is less than 0.2 mM (Garber et al. 1974; 
Courchesne-Loyer et al. 2013). Under ketosis, the concentration of BHB is around 1-2 mM and 
around 0.5 mM for AcAc after 3 days of fasting, and can reach as high as 8 mM, and between 1-2 
mM for AcAc for obese individuals after 42 days of fasting (Owen et al. 1967; Owen et al. 1969; 
Garber et al. 1974). Further, it was found that the ketone bodies also can provide up to two-thirds 
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of the brain’s energy requirement during ketosis (Owen et al. 1967; Courchesne-Loyer et al. 2013). 
Ketone bodies are generated in response to a change in the molar concentration of glucagon to 
insulin, as a result of a lower concentration of glucose circulating throughout the body (Mullins et 
al. 2011; Kanikarla-Marie and Jain 2016). Because the insulin content is so low, lipolysis is no 
longer inhibited, nor is hormone-sensitive lipase deactivated, allowing for fatty acids from adipose 
tissue to be metabolized (Laffel 1999; Kanikarla-Marie and Jain 2016). Therefore, the increase of 
cAMP, due to a high glucagon content, activates protein kinase A which signals for the enzyme 
adipose triglyceride lipase to begin hydrolysis of the triglycerides within adipose tissue (O’Neill 
et al. 2013; Steensels and Ersoy 2019). The newly formed diglycerides are then hydrolyzed by 
hormone-sensitive lipase to make monoglycerides, and glycerol (O’Neill et al. 2013; Steensels and 
Ersoy 2019). From here, the fatty acids are then released into circulation, and travels to various 
tissues through albumin (Laffel 1999; Steensels and Ersoy 2019). The fatty acid translocase/CD36, 
the most effective fatty acid transporter for increased fatty acid content, uptakes the fatty acids, 
and carnitine acyltransferase 1 then transports the fatty acids across the inner mitochondrial 
membrane, where beta-oxidation of fatty acids takes place to form acetyl CoA (Laffel 1999; 
Nickerson et al. 2009; Kanikarla-Marie and Jain 2016). Normally, under non-ketotic conditions, 
the acetyl CoA would enter the citric acid cycle, and condense with oxaloacetate (Laffel 1999). 
Since there is a lower content of glucose within the bloodstream, hepatic cells therefore utilize the 
oxaloacetate within gluconeogenesis, effectively slowing down the citric acid cycle (Laffel 1999). 
Further, under non-ketotic conditions, acetyl CoA could leave the inner mitochondria and be 
converted to malonyl CoA via acetyl CoA carboxylase, which is used for fatty acid biosynthesis 
(Laffel 1999). Though during ketosis, acetyl CoA carboxylase is inhibited by the increase in 
glucagon and lectin and decrease in insulin and adiponectin within the body, thus shunting these 
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pathways and using the acetyl CoA for the generation of ketone bodies (Laffel 1999; O’Neill et al. 
2013). Acetyl CoA is converted to acetoacetyl CoA by 3-ketothiolase, followed by the formation 
of β-hydroxy β-methylglutaryl CoA through mitochondrial β-hydroxy β-methylglutaryl CoA 
synthase, and cleaved to form AcAc by β-hydroxy β-methylglutaryl CoA lyase (Laffel 1999; 
Kanikarla-Marie and Jain 2016). AcAc is reduced to BHB by 3-hydroxybutyrate dehydrogenase, 
which oxidizes an NADH as a result (Laffel 1999; Kanikarla-Marie and Jain 2016). Acetone is 
also produced from AcAc by spontaneous decarboxylation (Laffel 1999). BHB and AcAc are the 
two dominant ketone bodies that are used as energy sources within the body (Laffel 1999; Fujii et 
al. 2014; Kanikarla-Marie and Jain 2016). The ratio between the two ketone bodies is usually three 
BHB molecules to one AcAc molecule, which is a result from the NADH/NAD+ ratio and activity 
of the 3-hydroxybutyrate dehydrogenase (Laffel 1999; Kanikarla-Marie and Jain 2016). 
The ketone bodies, being water soluble, travel throughout the blood stream to serve as an 
energy source (Laffel 1999; Kanikarla-Marie and Jain 2016). The ketones enter organs and are 
transported into the cell by monocarboxylate transporter 1 and 2 (Puchalska and Crawford 2017). 
Subsequently, the ketones travel through to the inner mitochondria for ketolysis, but the 
mechanism is unclear (Puchalska and Crawford 2017).The abundant BHB molecules revert back 
to AcAc by 3-hydroxybutyrate dehydrogenase (Branco et al. 2016). From here, the AcAc 
molecules are used to regenerate acetoacetyl CoA through the enzyme SCOT and an acetyl group 
is cleaved from methylacetoacetyl CoA thiolase to regenerate acetyl CoA which enters the citric 
acid cycle (Laffel 1999; Branco et al. 2016; Kanikarla-Marie and Jain 2016). It should be noted 
that SCOT is the rate limiting step of ketolysis, and the highest expression of this enzyme is in the 
heart and the brain (Laffel 1999; Kanikarla-Marie and Jain 2016). Further, SCOT is downregulated 
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by high concentrations of AcAc, which is the reason for an increase in circulating ketone bodies 
during the initial phases of ketosis (Laffel 1999). 
There are commercial methods for individuals to analyze ketone body concentrations. 
Commonly, urinary ketones are measured to screen individuals for diabetic ketoacidosis (Laffel 
1999). The urine kit relies on the Legal reaction, in which AcAc reacts in presence of an alkaline 
buffer and nitroferricyanide to produce a purple color on a test strip (Laffel 1999; Brooke et al. 
2016). This test does not react with BHB, nor does it measure the amount of ketones present (Laffel 
1999; Brooke et al. 2016). Measuring AcAc through urine is a cheap method to determine if 
someone is in a state of ketoacidosis; although it can be perceived as intrusive and awkward for 
people and is less accurate than measuring blood ketone levels, which primarily focuses on BHB 
(Brooke et al. 2016). Using a blood ketone monitor, the amount of BHB is quantitatively 
determined (Brooke et al. 2016). It is believed that BHB levels within blood provide fewer false 
positives than urine kits that test for AcAc. Also there is a higher correlation between blood BHB 
concentrations and the clinical markers of diabetic ketoacidosis (Brooke et al. 2016). Though, 
measuring blood has its challenges since the meters have difficulties measuring concentrations 
greater than 5 mM, can be seen as invasive, and the blood strips and meter is expensive to purchase 
(Brooke et al. 2016). Thus, it would be in the best interest of the public to develop a less invasive 
and affordable way to analyze ketone bodies, especially BHB, within the body. 
Saliva plays an important role within the body as it clears substances from the mouth, 
contains salivary amylase to break down carbohydrates, buffers pH, and protects, hydrates, and 
lubricates oral mucosal surfaces (Proctor 2016). Saliva consists mostly of water, but also contains 
hormones, microbes, enzymes, and other metabolites (Elmongy and Abdel-Rehim 2016; 
Viswanath et al. 2017). Most notably, saliva is isotonic to plasma (Aps and Martens 2005; 
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Elmongy and Abdel-Rehim 2016; Proctor 2016). The concept of using saliva as a diagnostic model 
is slowly gaining popularity within the literature, but there is very little research on the 
quantification of ketone bodies in the literature, not to mention quantifying the amount of BHB or 
AcAc within individuals undergoing ketosis (Elmongy and Abdel-Rehim 2016). Previously, it was 
noted that both saliva and blood contain BHB, and there is a positive correlation between them 
(Liu et al. 2015). The study done by Liu et al. also observed BHB within urine, but their subjects 
used were not in ketosis (2015). In another study, saliva was analyzed in diabetic patients and 
healthy volunteers for BHB, which was found to be around 25 ng/mL and 16.5 ng/mL, 
respectively, though the participants were also not in ketosis either (Tsutsui et al. 2012). AcAc was 
not explored in both experiments (Tsutsui et al. 2012; Liu et al. 2015).  
The instrument technique of gas chromatography-mass spectrometry (GC-MS) involves 
producing and separating gas phase analytes, and detecting these analytes by first ionizing them 
using a mass spectrometer (Niwa 1995). This technique has been used in previous experiments to 
quantify ketone bodies within biological fluids (Paul et al. 2006; Hassan and Cooper 2009; Holm 
et al. 2010; Føreid and Gadeholt 2017), and it is a very powerful technique to detect analyze the 
analytes of interest. The gas chromatograph separates gaseous analytes which are carried through 
a stationary column by an inert gas (Niwa 1995). In the column, the analytes are separated based 
on their affinity with the column and vapor pressure (Niwa 1995). The stationary phase interacts 
with the analytes and separates them based on their affinity to the non-polar column (Niwa 1995); 
the more non-polar the analyte is, the longer it takes for it to elute through the column (Niwa 1995). 
If the analyte has a high vapor pressure, it will travel through the column quickly as well (Niwa 
1995). Once it is separated, the analytes will be bombarded by electrons and ionized by an electron 
impact mass spectrometer, which then separates the charged ions through a mass analyzer by its 
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mass-to-charge ratio to obtain a mass spectrum (Niwa 1995). This allows for the investigators to 
determine what eluted from the gas chromatograph (Niwa 1995).  
Therefore, this experiment looks to quantify the amount of BHB and AcAc, the two most 
common ketone bodies, found in the saliva, blood, and urine via GC-MS before and after inducing 
ketosis in consenting participants. Through quantification, the development of methods that are 
non-invasive and cheap to purchase to observe the ketone body content within individuals can be 
explored. Within this study, method development was conducted to try and optimize the detection 
of the ketone bodies. From there, nine participants followed a ketogenic diet for four days, where 
their blood, urine, and saliva were sampled before-the-diet and after-the-diet. The ketone bodies 
were then extracted, analyzed, and quantified for each individual participant.  
 
2.0 METHODS 
2.1 Standards and Materials 
Lithium acetoacetate, (±)-sodium 3-hydroxybutyrate, and BSTFA + 1% TMCS were 
purchased from Sigma-Aldrich Canada Ltd. (Oakville, Ontario, Canada). The acetonitrile was of 
HPLC grade. The trichloroacetic acid and Tris were purchased from Sigma-Aldrich Canada Ltd. 
(Oakville, Ontario, Canada). The headspace vials were 20 mL and clear, while the caps were 18 
mm magnetic screw caps. Both were purchased from Canadian Life Science (Peterborough, 
Ontario, Canada). They were previously never used before the experiment. 
 
2.2 Ketogenic Diet 
Participants were recruited to participate in a KD through posters and word of mouth 
around the Thompson Rivers University campus. The participants contacted the investigators and 
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arranged a meeting time to further discuss the experiment. The participants were given a numbered 
consent form upon arrival for them to read over and was signed if they consented to participating 
in the study. They were then given a numbered screening questionnaire to complete so the 
investigators could determine if they were healthy enough to participate in the study. Both the 
consent forms and questionnaires were numbered in effort to keep the participant’s anonymous, 
and their name and corresponding number were recorded in a secure notebook. There were 10 
participants originally, but Participant 1 removed themselves from the study prior to starting the 
diet. 
The diet that the participants were following was a classic ketogenic diet that followed a 
3:1 ratio of fats to protein and carbohydrates. The participants were encouraged to follow the meal 
plan that was created by the investigators (see Appendix), but they were able to eat other food as 
long as they received permission from the investigators and recorded it in a meal log. The diet was 
followed for four days. Because the participants have different eating habits, they were encouraged 




The participants fasted for a minimum of 8 h prior to sampling. The participants were 
instructed to urinate a minimum of 10 mL into a centrifuge tube. The tubes were sealed, wiped, 
and given to the investigators. The participants were to passively drool a minimum of 500 µL into 
a 1.5 mL Eppendorf tube. This was done by sitting down, and arching their back to a 45° angle, 
and further directing their head downward to allow for the saliva to pool in their mouth. They then 
had to manipulate their mouth to allow for the saliva to enter the Eppendorf tube. They had to 
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ensure that the saliva was not bubbly as it would not give an accurate representation of the amount 
currently in the tube itself. The participants then had 5 mL of their blood drawn into lithium heparin 
tubes. The blood was placed on ice after the initial collection. This was conducted before the 
participants started the diet and 4 days after following the ketogenic diet. 
The urine was split into three 1.5 mL Eppendorf tubes as storage, and 500 µL of the sample 
was pipetted into a sterile Eppendorf tube for subsequent use within the experiment. The saliva 
was stored in its original container. The blood, after being drawn, was then centrifuged at 3000 rcf 
for 10 min at 4°C to separate the plasma. The plasma was then pipetted into 1.5 mL Eppendorf 
tubes as storage, and a 500 µL sample was taken to be used in the experiment. All fluids were then 
stored at -80°C until the samples were to be analyzed. 
 
2.4 Sample Analysis 
 All of the sample tubes that were stored were dethawed on ice. The plasma was then 
deproteinated to remove potential protein interferences within the plasma. There was 500 µL of   
2 M trichloroacetic acid that was added to the Eppendorf tube. It was then centrifuged at 13,000 
rpm for 3 min at 4°C. The supernatant was moved, and 250 µL of 4 M Tris was then added. The 
solution was then centrifuged at 13,000 rpm for 15 min at 4°C. It was also brought back to pH 7 
using KOH. Once the saliva had dethawed, the sample was centrifuged at 13,000 rpm for 10 min 
to pellet the mucins within the fluid. Afterwards, 200 µL of each fluid was pipetted into a new 
headspace vial, along with 10 µL of 70% ethanol. The solution was capped, mixed, and it sat for 
1 h in order to sterilize the fluids. The vials had their caps removed, and the solutions inside were 
evaporated in an oven at 80°C. After the evaporation, 75 µL of BSTFA + 1% TMCS and 150 µL 
of acetonitrile were added to each headspace tube, were capped, and derivatized at 80°C for 1.5 h. 
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They were subsequently left at room temperature for three days afterwards. The samples were 
agitated at 250 rpm for 6 min at 80°C prior to analysis. The PAL headspace syringe, at 85°C, then 
penetrated through the vial cap and sampled 100 µL of headspace and injected it into the GC-MS.  
 
2.5 Instrumental Conditions 
Analysis was performed using an Agilent 7890B-GC coupled 5977A-MS (Agilent 
Technologies, Santa Clara, CA). The instrument operated using a PAL RSI 85 autosampler system 
equipped with a headspace function and an agitator with an oven. The column was an Agilent HP-
5MS column (30 m x 250 µm x 0.250 µm) (Agilent Technologies, Santa Clara, CA). An agitator 
on the autosampler was heated to 80°C, and the syringe was heated to 85°C. The split was 2:1, and 
the split flow was 2 mL/min. The injector temperature was 250°C. The temperature program used 
was developed from a previous method (Hassan and Cooper 2009). The initial oven temperature 
was 60°C and was held at this temperature for 2 min. The temperature increased to 180°C at 
20°C/min, and then increased to 250°C at 50°C/min which was then held for 1 min. The total run 
time was 10.4 min. The amount injected was 100 µL. 
A scan on the mass spectrometer was used to detect the ions from 40-350 m/z. The ion 
chromatograms were extracted using selected ion monitoring to determine where the ketone bodies 
were eluting at. The ions 147 and 233 were used to identify the BHB, and 147 and 231 were used 
to identify AcAc; the 147 ion was used to determine the concentration of the ketone bodies. As 
well, the NIST database was used in elucidating the mass spectrum to help estimate the compound 
that eluted from the gas chromatograph (Linstrom and Mallard 2001). This software estimates the 
compounds that eluted from the instrument, giving a probability of accuracy, based on the mass 
spectrum of the peak at that specific point (Linstrom and Mallard 2001). 
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2.6 Preparation and Analysis of the Ketone Body Standards 
A stock solution of 5000 ppm was made for BHB and AcAc, individually. The BHB stock 
solution was made up in a 50 mL volumetric flask with 18 MW water, while the AcAc solution 
was made up to 25 mL with 18 MW water. These stocks solutions were used to develop standards 
with concentrations of 50 ppm, 100 ppm, 250 ppm, 500 ppm, 1000 ppm, and 2000 ppm, made up 
to 10 mL with 18 MW water in a volumetric flask. The standards were mixed, and 225 µL of each 
solution was added to a new headspace vial. The solution was evaporated in an oven at 80°C. The 
solution then had 75 µL of BSTFA + 1% TMCS and 150 µL of acetonitrile added to each vial. 
They were derivatized in the oven for 1.5 h at 80°C and were run three days afterwards. Before 
analysis, the samples were agitated at 250 rpm for 6 min at 80°C. The PAL headspace syringe then 
was used to inject 100 µL of the standards headspace into the GC-MS.  
 
3.0 RESULTS AND DISCUSSION  
3.1 Detection and Calibration of the Ketone Bodies  
The development of a method to detect the ketone bodies was investigated using the BHB 
standard. This standard was used for method development because of its prominence within the 
blood of individuals producing ketone bodies (Laffel 1999; Fujii et al. 2014). A mass of BHB was 
added into hexane, acetonitrile, water, and methanol. It was not soluble in the hexane since nothing 
seemed to be dissolved, but it was soluble in methanol, water, and acetonitrile; it was most soluble 
in methanol and water. Therefore, the BHB standard was dissolved in 18 MW water to create the 
stock solutions. The solution was then pipetted into a glass headspace vial, where the solution was 
evaporated to dryness using nitrogen gas. This was inefficient and extremely difficult to do, so the 
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headspace vials were transported to an oven which was set to 80°C to evaporate the solvent. The 
derivatizing agent was then pipetted into the vial, it was capped, and the vial was heated to promote 
the derivatization reaction. Upon analysis, there was no signal that was ascertained. Therefore, the 
stock solution would be acidified to ensure that all of the hydroxyl groups were protonated to help 
with the derivatization reaction. The same procedure was then conducted, but there were still no 
results that were ascertained. Acetonitrile was then added as a catalyst for the derivatization to take 
place, especially since BHB is soluble in it. There was a BHB signal detected with the GC-MS. 
The signal obtained had a mass-to-charge ratio at 147 and 231, and the NIST database predicted 
this molecule to be a trimethylsilyl beta-hydroxybutyrate molecule as result of the derivatization. 
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(a 
(b 
Figure 2. The chromatogram (a) of 5000 ppm derivatized BHB with its corresponding mass 
spectrum (b). The BHB signal is found at 6.521 min. 
 
Next, we determined how much acetonitrile to be added to help the derivatization occur. 
In each reaction, 225 µL of 5000 ppm BHB stock solution was added to a headspace vial and 75 
µL of BSTFA + 1% TMCS was added; the amount of acetonitrile added was 75, 150, and 225 µL 
to each reaction afterwards. All were derivatized for 25 min at 80°C, and it was found that the 150 
µL solution produced the highest signal for BHB. The optimal time of the derivatization was 
determined afterwards. A sample that was produced during the method development for the 
optimal amount of acetonitrile added was analyzed one month following to its initial derivatization 
was found to have an extremely large peak area. Because of this, it was assumed that the amount 
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of time the initial derivatization in the oven was for was irrelevant as the derivatization seemed to 
occur for longer than anticipated. A solution was then derivatized in an oven for 1.5 h at 80°C to 
aid in as much derivatization as possible and was then kept at room temperature and analyzed 
every day. The solution seemed to have the same peak area on the third and fourth day of analysis. 
Therefore, the solutions were to be derivatized for 1.5 h at 80°C and then placed in a room 
temperature environment for the next three days before they were analyzed by the GC-MS. 
The next standard that was used was AcAc. This standard was difficult to use since its 
chromatograms had many impurities, and the peak area was not as high as it was for BHB. A 2000 
ppm stock solution was made for method development nonetheless, and the peak obtained was 
very small, especially in comparison to the BHB peak area. This standard had two derivatizations 
occur instead of one. AcAc has one hydroxyl group, but based on the mass spectra and the NIST 
database, it seemed like there were two derivatizations occurring. The carboxylic acid remained 
the same, but the lone carbonyl tautomerized and was subsequently converted to a hydroxyl group 
which was also derivatized. 
The AcAc standard solution was not acidified to see if it had any effect on the end result. 
This produced a chromatogram that had a greater peak area than the one previously seen with the 
acidified AcAc. Therefore, the experimental procedure for BHB was reexamined since both ketone 
bodies were predicted to be within the biological fluids. The BHB sample solution was not 
acidified, derivatized, and subject to analysis; the results showed that it still had a distinct signal, 
but the peak area was not as high as it was for the acidified BHB. In an effort to detect quality 
ketone body signals, the solutions were not acidified to aid in detecting AcAc among the biological 
samples. Figure 3 includes a chromatogram and mass spectrum for AcAc. 
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(a 
(b 
Figure 3. The chromatogram (a) of 5000 ppm derivatized AcAc with its corresponding mass 
spectrum (b). The AcAc signal is found at 7.197 min. 
 
A calibration curve was produced for both analytes separately. This was done by preparing 
standards of increasing concentrations and obtaining the peak areas of each signal and plotting it 
on a graph. The concentrations used were 50 ppm, 100 ppm, 250 ppm, 500 ppm, 1000 ppm, 2000 
ppm, and 5000 ppm. The range of concentrations was very wide in an effort to account for the 
variation in ketone bodies produced by each individual. These solutions were analyzed in triplicate, 
save for the 100 ppm standard of BHB which was analyzed in duplicate; this is because the run 
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had an error which stopped the run before the BHB signal was analyzed. The derivatized ketone 
bodies that the mass spectrometer detected are found in Figure 2. 
 
Figure 4. The derivatized acetoacetate (a) and beta-hydroxybutyrate (b) that were to be analyzed 
by the GC-MS.  
 
For the BHB standard curve, there was a trend of linearity based on the coefficient of 
variation (R2=0.9742). The limit of detection (LOD) for the BHB standard curve was found using 
the standard deviation of the lowest concentration standard used divided by the slope of the curve 
and multiplied by 3. Likewise, the limit of quantification (LOQ) was found in the same manner 
but was multiplied by 10 instead of 3. The LOD and the LOQ was found to be 26.48 ppm and 
88.28 ppm, respectively. Other papers have determined the LOD to be 0.833 ppm (Holm et al. 
2010), and 10 ppm (Paul et al. 2006). The closest to the LOD obtained in this experiment is by 
Paul et al., but that result is much smaller than the results experimentally determined. Because of 
this, the method should be further optimized since this method isn’t able to detect low levels of 
ketone bodies as effectively as the other methods do. One way to do this could be to run many 
trials, and then average the spectra together to lower the signal-to-noise ratio. 
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Figure 5. The beta-hydroxybutyrate standard curve using the GC-MS. 
 
For the AcAc standard curve, the GC-MS was not able to detect the ketone body standards 
below 1000 ppm. It also produced unreliable signals for standards that were greater than 500 ppm 
as the 2000 ppm standard seemed to have a peak area consistently larger than 5000 ppm. Because 
the chromatogram had many foreign peaks as well, it was suspected that the standard was 
contaminated. Upon obtaining a second batch of AcAc, it also seemed to have foreign peaks and 
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3.2 The Qualitative Results of the Diet 
The participants were to follow a ketogenic diet in an effort to produce ketone bodies within 
their body. The participants were to eat 3 g of fats for every 1 g of protein and carbohydrates. Each 
participant documented what they ate, and the time they ate the food at. They were encouraged to 
eat food until they were full, and not eat a specific amount of calories.  
The first meal that was recorded was breakfast. It was defined as a substantial meal that 
was ingested before 10:30 am. Because each participant had different eating habits, this meal was 
not forced upon the participants. The food that was consumed by the participants were recorded 
and displayed in Table 1. It was the least consumed meal as there were two participants (2 and 4) 
who exclusively did not eat breakfast; Participant 5 and 6 each had breakfast only on one day, and 
Participants 7 and 8 seemed to have only tea in the morning save for the Day 2 breakfast for 
Participant 7. For those who did not eat breakfast, their body would be in a fasting state which 
would increase the amount of triglycerides that were eventually oxidized to produce ketone bodies 
(Mullins et al. 2011; Kanikarla-Marie and Jain 2016). As for those who ate a breakfast, they mainly 
ate some form of eggs with or without bacon which are both higher in protein and fat content. This 
is fine since biochemical pathways will prefer to use triglycerides as an energy source before 
proteins (Kanikarla-Marie and Jain 2016). Though the protein content is high, the amount of 
carbohydrates ingested were very low. This is beneficial since the amount of glucose circulating 
within the blood is minimized. Therefore, it seemed like the participants were following the 
ketogenic diet during breakfast.  
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Table 1. The breakfast consumed by each participant during the course of the diet.  














N/A Bacon and 
Eggs 
N/A Omelette N/A English tea 












N/A Bacon and 
Eggs 






























































The second meal that was recorded was lunch. It was defined as a substantial meal that was 
ingested after 10:30 am and before 4:00 pm since each participant would have different eating 
habits and schedules. The food that was consumed by the participants at lunch were recorded and 
displayed in Table 2. Lunch was eaten by all of the participants, but Participant 3 only consumed 
lunch 2 out of the 4 days. It’s worth considering that this participant was also not consuming 
breakfast; there is a chance that this participant was producing many ketone bodies as a result of 
this fast. The meals that were eaten seem to consist of a lot of vegetables, mainly in the form of a 
salad. There was also a noticeable amount of bacon and pork chops consumed. The vegetables 
contain many vitamins that the participants would be ingesting during the course of the diet; they 
themselves have little protein, fat, and carbohydrates. Pork chops have a high protein content, but 
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there still is a substantial amount of fat which is still relevant for the purpose of the diet. Bacon 
has more fat then protein, which is extremely beneficial for the purpose of this diet. There does 
not seem to be any particular meal with a high content of carbohydrates which would therefore 
hinder the results of this experiment. Thus, it seemed like the participants were following the 
ketogenic diet during lunch.  
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4 eggs with 
bacon 

























































































































The third meal that was recorded was dinner. It was defined as a substantial meal that was 
ingested after 4:00 pm and before 8:30 pm since each participant would have different eating habits 
and schedules. The food that was consumed by the participants at dinner were recorded and 
displayed in Table 3. Every participant ate dinner for the duration of the ketogenic diet, except for 
Participant 9 who did not eat dinner on Day 4. There seemed to be a large amount of protein eaten 
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during this time; the protein includes burgers and chicken mainly, but other options like pork chops 
and steak. The burgers all seem to have been eaten with a lettuce bun, save for Participant 8 on 
Day 2. This is beneficial since the bread is a source of carbohydrates which would have potentially 
tamper the results of the experiment. As for Participant 8, the participant seemed to still consume 
a high enough content of fats in comparison to the amount of carbohydrates eaten, so the effect of 
glucose within the bloodstream may be minimized. Chicken has a higher content of protein in it, 
but there still is a fat content making it suitable for the diet. Other than the previously mentioned 
dinner, there does not seem to be any particular meal with a high content of carbohydrates which 
would therefore hinder the results of this experiment. The tacos consumed by Participants 7 and 8 
slightly raise a flag because the taco shell contains carbohydrates, but there should be enough fat 
within the meal that minimizes the effects of the carbohydrates. Thus, it seemed like the 
participants were following the ketogenic diet during dinner.  
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3 tacos with 
lettuce as a 
bun, ground 
beef, onion, 




3 tacos with 
lettuce as a 
bun, ground 
beef, onion, 



















































served with a 
side Caesar 
salad with 

























































































































The last meal that was recorded was snacks that would occur throughout the day. To be a 
snack, it had to be eaten at a separate time from when the three major meals were consumed and 
in a lesser amount. Snacks also included beverages that were had throughout the day that weren’t 
designated as a breakfast drink or water. The food that was consumed by the participants as snacks 
were recorded and displayed in Table 4. Majority of the participants had snacks throughout the 
day. The snacks seem to be potentially worrisome in regard to the carbohydrates being consumed. 
For instance, Participants 7 and 8 both consumed beer and carrots which are extremely high in 
carbohydrates. Their dinners also had a higher amount of carbohydrates in comparison to the other 
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participants. Because of this, they may have ingested more carbohydrates than fats, and 
compromised their results for the experiment. Of course, this would have to be determined based 
on the analysis of their biological fluids. Pepperoni sticks were the most common snack that was 
ingested. This food contains an extremely high concentration of fat in it, a moderate amount of 
protein, and essentially no carbohydrates. This was an ideal food to snack on during the duration 
of the diet. Participants 7 and 8 did eat these, but it is unclear if they ate enough for it to make the 
carbohydrates they consumed to follow the 3:1 ketogenic diet ratio. In general, it seemed like the 
snack foods had very little carbohydrates in it. 
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In general, the participants overall ate minimal carbohydrates, but they did consume a large 
amount of protein and fat. The targeted ratio of fat to protein and carbohydrates was supposed to 
be 3:1. Based on the food that was ingested, it seems like the amount of fats consumed was 
essentially the same compared to the amount of fats, and that the carbohydrates consumed were 
much lower. It seemed like the participants ended up following the Atkins diet eating a ratio closer 
to 60% fats, 30 % protein, and 10% carbohydrates, as opposed to the classical diet (Kang et al. 
2007). Even though the diet has changed, blood ketosis is still probable as previous studies have 
recorded patients having BHB levels greater than 3 mM within 3 days of following the diet (Kang 
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et al. 2007). But it is worth noting that the amount of food and the way it was cooked was not 
recorded, so there is a chance that there are more carbohydrates within the meals than was written 
by the participants. There is also a chance that the participants did not write down all of the food 
they ate, and they cheated on the diet. Though difficult to prove, it is worth considering when 
observing the results from the analysis.   
 
3.3 The Quantification of Ketone Bodies  
3.3.1 Quantification in Blood 
Blood is one of the most accurate ways to determine the concentration of ketone bodies 
within the individual as ketone bodies circulate through the body via blood (Laffel 1999; 
Kanikarla-Marie and Jain 2016; Brooke et al. 2016). The sample was then brought back to 
physiological pH because acetoacetate was better able to be derivatized and detected at pH 7 
compared to below pH 2. The samples were analyzed in duplicate on the GC-MS, and the results 
are displayed in Table 5. Based on the results, it seems like Participant 2, 4, 5, and 8 seem to have 
increased the amount of BHB within their blood. Each trial of Participant 2’s blood was able to 
detect BHB, which strengthens the argument that there was an increase in the levels of BHB 
circulating their body. Both Participants 4 and 8 did not have a BHB signal detected before the 
diet occurred, which could mean that the amount of BHB within their system was below the LOD 
and LOQ of the instrument, or that there was variation within the instrument during the different 
runs. Participants 6, 7, 9, and 10 seem to have a lower amount or similar amount of BHB in the 
after-the-diet compared to the before-the-diet samples. This could result from the participants not 
following the diet that was prescribed to them. By eating carbohydrates, their body would not have 
shunted glycolysis and the citric acid cycle, which would have resulted in little amounts of ketone 
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bodies produced. Another reason why BHB may have been detected could be a result of the 
participants fasting longer than 12 h as the concentration of BHB increases over time (Marinou et 
al. 2011). Statistics were not conducted since not every participant was able to generate average 
values of BHB before and after the diet.  
 





























2 1 245.46 6.520 274.96 390.89 6.521 398.09 
2 2 304.48 6.519 405.29 6.520 
3 1 0 N/A N/A 0 N/A N/A 
3 2 248.90 6.519 268.83 6.520 
4 1 0 N/A N/A 240.48 6.522 245.45 
4 2 0 N/A 250.43 6.520 
5 1 0 N/A N/A 0 N/A N/A 
5 2 246.69 6.519 339.99 6.520 
6 1 0 N/A N/A 0 N/A N/A 
6 2 247.04 6.520 258.12 6.520 
7 1 250.64 6.519 261.75 247.34 6.518 247.05 
7 2 272.86 6.520 246.75 6.5117 
8 1 0 N/A N/A 240.24 6.52 242.22 
8 2 0 N/A 244.21 6.518 
9 1 0 N/A N/A 0 N/A N/A 
9 2 266.06 6.521 283.55 6.646 
10 1 0 N/A N/A 239.60 6.519 254.09 
10 2 257.57 6.519 268.58 6.518 
 
Interestingly enough, it seems like the results agreed with the results that were expected 
within the blood. By converting the concentrations in ppm to mM, the amount of BHB within the 
blood samples seem to agree with the results of previously found by Owen et al. (1967), Owen et 
al. (1969), Galvin et al. (1968) and Garber et al. (1974) being in between around 1-2 mM after 4 
days. There is variation between individuals as everyone has a slightly different metabolism and 
ate slightly different foods. It is also worth acknowledging that Participant 2 had a concentration 
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of 3.82 mM of BHB which refers to potential ketoacidosis arising based on the symptom 
ketonaemia (Laffel 1999; Usher-Smith et al. 2011). It is unknown if that was the situation since 
the blood glucose and blood pH was not measured, but it is possible.  
Within the blood, there was no AcAc signals detected in any of the samples. It is possible 
that there was AcAc within the blood samples, but the concentration was below the LOD. In the 
future, certified reference material should be utilized during method development to help quantify 
the AcAc from within the blood. 
There are many runs where there is no signal detected. It does not necessarily mean that 
there were no ketone bodies present within the fluid, but that it may have been below the LOD. As 
well, there was no internal standard used which would have been used to determine if there was 
any variation between runs. It does seem like there was variation between runs since some samples 
have BHB detected in one trial, but not the other trial. It is unknown what could have caused that 
variation between runs to occur.  
 
3.3.2 Quantification in Urine 
The participants also had their urine collected before and after conducting the diet. The 
samples were analyzed in duplicate on the GC-MS, and the results are displayed in Table 6. There 
was no AcAc detected in the urine. This is somewhat surprising since it is measured in commercial 
methods currently (Brooke et al. 2016). A possible reason could be that the urine had an acidic pH 
and was not adjusted to pH 7. Because of this, there needs to be further method development 
conducted to ensure that AcAc is observed within urine. As well, there was an extremely high 
amount of BHB recorded within urine. The amount of BHB was negligible for all of the 
participants before the diet, but they almost all seemed to have higher BHB levels within their 
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urine than in their blood. Statistics were not conducted since not every participant was able to 
generate average values of BHB before and after the diet. 
 



























2 1 0 N/A  N/A 
 
7461.37 6.521 9572.11 
2 2 0 N/A 11682.8
5 
6.520 
3 1 0 N/A N/A 871.75 6.520  663.56 
 3 2 0 N/A 455.37 6.521 
4 1 0 N/A  N/A 294.94 6.523 369.18 
4 2 0 N/A  443.423 6.521 
5 1 0 N/A  N/A 276.17 6.522  278.74 
5 2 0 N/A  281.31 6.523 
6 1 0 N/A  N/A 1133.22 6.520 1042.82 
6 2 0 N/A  952.41 6.519 
7 1 0 N/A  N/A 324.80 6.520 349.49 
7 2 0 N/A  374.19 6.520 
8 1 0 N/A  N/A 269.51 6.523 275.54 
8 2 0 N/A  281.56 6.524 
9 1 0 N/A  N/A 350.65 6.520 366.65 
9 2 0 N/A  382.65 6.520 
10 1 0 N/A  N/A 1103.14 6.519 1553.35 
10 2 0 N/A  2003.56 6.520 
 
 In a study conducted by Liu et al., they observed participants biological fluids after fasting 
a minimum of 9 h and found 0.12 µM of BHB in urine compared to 68.8 µM in plasma (2015). 
Based on this piece of data, it seems like BHB is at a higher concentration within the bloodstream 
than it is within urine. But in the past, as ketosis occurs for a longer period of time, the amount of 
AcAc in urine decreases and the amount of BHB excreted increases (Galvin et al. 1968). Though, 
it is difficult to compare how much AcAc and BHB were analyzed since it was in units of µmol/min 
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(Galvin et al. 1968). Nonetheless, it is still believed that the amount of BHB detected is positively 
skewed since the urine is acidic. Having acidic urine would likely derivatize more BHB within the 
vial, thus a higher concentration was seen by experiment. To know for sure, the experiment would 
have to be conducted again, except there would have to be a control for the pH of urine.  
 
3.3.3 Quantification in Saliva 
Saliva was also collected and analyzed to see how much ketone bodies were present. Saliva 
is becoming a more popular diagnostic model to use as it is less invasive and isotonic to plasma 
(Aps and Martens 2005; Elmongy and Abdel-Rehim 2016; Proctor 2016). The concept of 
quantifying ketone bodies within saliva in ketotic participants is rather novel. The samples were 
analyzed in duplicate on the GC-MS, and the results are displayed in Table 7. There was no AcAc 
detected in the saliva. It was expected that it would have very little amounts of AcAc since saliva 
is isotonic to blood which contains a small amount of AcAc in it (Liu et al. 2015). As for BHB, 
there was very little signal that was detected overall. There were 4 signals that were obtained from 
the before-the-diet samples. The concentration of BHB in these samples are very similar to the 
results obtained in these participants bloods samples. There were only two signals obtained in the 
after-the-diet samples by Participant 3 and 4. These signals were smaller than the signal detected 
in the before-the-diet sample for these participants. Theoretically, it should be higher since the 
ketogenic diet would have occurred, increasing the amount of ketone bodies within the individuals. 
Statistics were not conducted since not every participant was able to generate average values of 
BHB before and after the diet. 
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2 1 253.70 6.520 249.59 0 N/A N/A 
2 2 245.48 6.520 0 N/A 
3 1 253.22 6.521 N/A 0 N/A N/A 
3 2 0 N/A 243.84 6.519 
4 1 244.44 6.518 N/A 240.48 6.522 N/A 
4 2 0 N/A 0 N/A  
 
 In a study conducted by Liu et al., they previously observed participants biological fluids 
after fasting a minimum of 9 h and found 1.74 µM of BHB in saliva compared to 68.8 µM in 
plasma (2015). Based on this result, it would be expected that there is some BHB detected, but not 
as much as in the blood. There are two potential reasons why the amount of signal detect was very 
low. The first could be that the amount of BHB within the sample was below the LOD, which is 
logical considering the amount of BHB in the plasma is almost 40x larger than that observed in 
the saliva (Liu et al. 2015). The other reason is that there was not a lot of BHB that was derivatized 
within the sample, so the signal was very low as a result. Likewise, the samples that did produce a 
signal could have had a very effective derivatization by chance. A way to improve upon this would 
be to add a recovery standard to determine how effective the derivatization was to ensure that all 
of the potential analyte was derivatized and detected.  
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4.0 CONCLUSIONS 
In conclusion, participants underwent a ketogenic diet to induce ketosis; samples of their 
blood, urine, and saliva were collected before and after the diet to determine if BHB and AcAc 
could be quantified through the GC-MS. The conditions were moderately optimized to obtain the 
best possible signals for the BHB and AcAc ketone bodies for the time being. A calibration curve 
for BHB was produced (R2 = 0.9742) and was used to quantify the amount of ketone bodies present 
in the biological samples. For the participants whose blood samples were able to be quantified, it 
seems like they were in ketosis and the amount of BHB seems within range of what was expected. 
The urine samples had a high concentration of BHB, which could be a result of the acidic urine 
which would help in the derivatization step, so it could be analyzed. There was very little signal 
detected within saliva, but the fact that signal was detected means that this could potentially act as 
a method to quantify ketone bodies upon more method development. 
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5.0 FUTURE WORK 
Future work for this research would look to optimize the detection of AcAc from 
biological fluids. Possible ideas include trying to separate this ketone body from the BHB and 
using a different derivatizing agent to make it volatile. Future work should also consider using 
two recovery standards to know how effective the derivatization is, and if any analyte is lost 
during the matrix evaporation step. Adding an internal standard would be useful to determine if 
there is any variation between runs. Another idea for future work would be to control the pH 
across all biological fluids since it seems like urine produced a higher signal because the acidity 
of the matrix favored the derivatization reaction to occur. Lastly, optimizing a better method to 
extract, derivatize, and analyze the BHB from saliva. Possible ideas include acidifying the pH of 
a sample to protonate the analyte in an effort to do liquid-liquid microextraction with hexane. 
Then, concentrating the solution and derivatizing it. This may be effective for detecting BHB, so 
the future work on AcAc will dictate if the method would change to detect the amount of AcAc 
in the biological fluid. Potentially, this method could be used on all biological fluids as well.  
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Participant 2 Urine After-The-Diet (Trial 1) 
 
 
Comparison Between Acidified Beta-Hydroxybutyrate (a) and Non-Acidified Beta-
Hydroxybutyrate at 5000 ppm Each 
(a 
(b 
  43 


















  45 
Biosafety Approval  
 
